Gastroenteritis and related diarrhoeal diseases affect hundreds of millions of people each year. The figures below show the scale of illness, healthcare use, deaths, and prevention-related trends, while keeping each estimate’s definition, geography, and measurement period explicit.
Contents
- Global childhood burden
- Acute gastroenteritis in the U.S. community
- Norovirus in the United States
- Rotavirus in U.S. children
- Foodborne gastroenteritis in the United States
- Global rotavirus burden and trends
Global childhood burden
The World Health Organization’s Diarrhoeal disease fact sheet reports nearly 1.7 billion cases of childhood diarrhoeal disease worldwide each year. This is a broad diarrhoeal-disease measure, not a count of infectious gastroenteritis alone. WHO reports that diarrhoeal disease kills around 443,832 children younger than 5 years annually and an additional 50,851 children aged 5–9 years. It is the third leading cause of death among children aged 1–59 months. These are annual estimates published in 2024. (WHO, “Diarrhoeal disease”)
Exposure and prevention conditions remain important parts of the global picture. In low-income countries, children younger than 3 years experience an average of three diarrhoeal episodes per year, according to the same WHO source. Worldwide, 780 million people lack access to improved drinking-water, while 2.5 billion lack improved sanitation. These figures describe population-level water and sanitation access, not the individual cause of any one episode.
WHO identifies rotavirus, norovirus, adenovirus, and astrovirus as the most common viral pathogens among children younger than 5 years with diarrhoeal disease. It also describes three clinical types: acute watery, acute bloody, and persistent diarrhoea. Persistent diarrhoea is defined as lasting 14 days or longer. The pathogen and clinical classifications were reported in 2024 and should not be treated as interchangeable with a gastroenteritis case definition.
Acute gastroenteritis in the U.S. community
A 2022 CDC-published study estimated that acute gastroenteritis causes 179 million illnesses annually in the United States. Its Community Acute Gastroenteritis Study followed Kaiser Permanente Northwest members in Oregon and Washington from September 2016 through September 2017. Because the participants came from that regional health-system population, the findings are not a nationally representative survey. (CDC, “Incidence, Etiology, and Healthcare Utilization for Acute Gastroenteritis in the Community, United States”)
Among that study population, 30-day prevalence of acute gastroenteritis was 10.4%, while diarrhea-only illness had a 30-day prevalence of 7.6%. The annualized acute-gastroenteritis rate was 1.27 cases per person, compared with 0.92 diarrhea-only cases per person. These rates reflect the study’s definitions and recall period rather than a universal rate for every U.S. community.
Healthcare use was lower than total illness occurrence: 19% of people with acute gastroenteritis in the study sought medical care. Laboratory results also showed that at least one viral pathogen was detected in 22.4% of stool specimens from participants reporting acute gastroenteritis, compared with 8.2% of specimens from participants without reported acute gastroenteritis.
That difference between community illness and recorded care is central to interpreting burden statistics. A survey can capture people who recover at home, whereas hospital and clinic figures capture only a portion of the illness experience. The measures therefore answer different questions and should not be substituted for one another when comparing studies.
Earlier U.S. FoodNet studies using 1996–1999 data reported acute-gastroenteritis prevalence ranging from 7.7% to 11%. Earlier U.S. studies estimated roughly 0.7–1.4 acute-gastroenteritis illnesses per person per year, depending on recall period and case definition. Those historical results should be read as estimates from their original methods, not as independently verified current counts.
Norovirus in the United States
CDC’s Norovirus Facts and Stats page reports that norovirus causes an estimated 19–21 million illnesses annually in the United States. The same May 2024 estimates attribute about 109,000 hospitalizations, 465,000 emergency-department visits, 2,270,000 outpatient-clinic visits, and about 900 deaths to norovirus each year. (CDC, “Norovirus Facts and Stats”)
| U.S. annual norovirus outcome | CDC estimate |
|---|---|
| Illnesses | 19–21 million |
| Hospitalizations | About 109,000 |
| Emergency-department visits | About 465,000 |
| Outpatient-clinic visits | About 2,270,000 |
| Deaths | About 900 |
CDC estimates that norovirus causes 58% of foodborne illnesses acquired in the United States. The country has about 2,500 reported norovirus outbreaks each year. Foodborne norovirus illness costs about $2 billion per year in lost productivity and healthcare expenses. These are modeled or summarized annual estimates reported in May 2024, rather than a direct count of every case in 2026.
The burden also appears in pediatric care. Nearly 1 million U.S. pediatric medical-care visits are attributable to norovirus each year. By age 5, about 1 in 160 children will have been hospitalized for norovirus, about 1 in 40 will have visited an emergency department, and about 1 in 7 will have visited an outpatient clinic. These cumulative risks describe U.S. children through age 5, not annual probabilities.
Rotavirus in U.S. children
Rotavirus figures from CDC sources provide a useful prevaccine-era baseline. At least 95% of U.S. children had been infected by age 5 in prevaccine-era estimates. Before vaccine-era reductions, rotavirus caused more than 400,000 doctor visits and more than 200,000 emergency-room visits annually among U.S. children. It caused an estimated 55,000–70,000 hospitalizations and 20–60 deaths each year. (CDC, “Norovirus Facts and Stats”; CDC, “Rotavirus”)
The prevaccine-era estimate was about 2.7 million rotavirus cases per year in the United States. Rotavirus represented 5%–10% of gastroenteritis episodes among U.S. children younger than 5 years in prevaccine estimates. Annual direct and indirect U.S. rotavirus costs were estimated at approximately $1 billion before vaccine-era reductions.
These numbers are historical baselines, not current counts. The source labels them as prevaccine-era estimates, so they are most useful for understanding the scale of disease before vaccine-related reductions rather than describing present-day U.S. incidence.
Foodborne gastroenteritis in the United States
CDC’s burden assessment based on 2011 data estimated 9.4 million annual illnesses from 31 important known foodborne agents in the United States. Those agents were estimated to cause 55,961 hospitalizations and 1,351 deaths each year. (CDC, “Burden of Foodborne Illness: Questions and Answers”)
The same assessment separately modeled unspecified agents in food consumed in the United States. It estimated 38.4 million gastroenteritis illnesses, 71,878 hospitalizations, and 1,686 deaths annually from unspecified foodborne agents. Combining illnesses attributed to contaminated food produced an estimate of 47.8 million cases annually, 127,839 hospitalizations, and 3,037 deaths.
Because these categories use different levels of attribution, the known-agent and unspecified-agent figures should not be added to unrelated gastroenteritis estimates. They are components of the CDC’s foodborne-burden framework, based on a 2011 assessment, rather than direct surveillance totals for a single recent year.
CDC also estimated the burden for seven major pathogens in 2019. Excluding Toxoplasma gondii, those pathogens were associated with 9.9 million domestically acquired foodborne illnesses and 53,300 domestically acquired foodborne hospitalizations in the United States. (CDC, “Estimates: Burden of Foodborne Illness in the United States”)
Global rotavirus burden and trends
WHO’s Rotavirus vaccines: WHO position paper – July 2021 reports that before rotavirus vaccines became available in 2006, nearly every child worldwide was infected by age 3–5 years. In 2000, rotavirus caused more than 500,000 childhood deaths worldwide and more than 2 million hospitalizations among children younger than 5 years. (WHO, “Rotavirus vaccines: WHO position paper – July 2021”)
Later global figures show a different measurement point. In 2013, rotavirus deaths accounted for about 3.4% of all child deaths, and the rotavirus mortality rate was 33 deaths per 100,000 children younger than 5 years. The 2000 and 2013 values are separate historical estimates; they should not be interpreted as a single continuous annual series.
Across these sources, the main comparison is between broad diarrhoeal disease, clinically defined acute gastroenteritis, pathogen-specific estimates, and foodborne-attribution models. A number labeled “annual” may be a modeled estimate, a prevaccine baseline, or a study-derived rate. Geography, age range, case definition, and measurement period therefore matter as much as the headline number when interpreting gastroenteritis statistics.